Benzinga | Aug 4, 2021 05:40PM EDT

Agilon Health Q2 EPS $(0.79), Adj. EBITDA Loss $2M, Sales $498.96M Beat $473.29M Estimate

Agilon Health (NYSE:AGL) reported quarterly losses of $(0.79) per share. The company reported quarterly sales of $498.96 million which beat the analyst consensus estimate of $473.29 million by 5.42 percent.